| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A novel hypothesis for the etiology of pneumococcal co-infection in influenza
|
Eisenhut, Michael
|
|
2010
|
28 |
4 |
p. 879-
1 p.
|
article
|
| 2 |
A universal anti-HIV-1 Tat epitope vaccine that is fully synthetic and self-adjuvanting
|
Goldstein, Gideon
|
|
2010
|
28 |
4 |
p. 1008-1014
7 p.
|
article
|
| 3 |
A vectored equine herpesvirus type 1 (EHV-1) vaccine elicits protective immune responses against EHV-1 and H3N8 equine influenza virus
|
Van de Walle, Gerlinde R.
|
|
2010
|
28 |
4 |
p. 1048-1055
8 p.
|
article
|
| 4 |
B cell responses to H5 influenza HA in human subjects vaccinated with a drifted variant
|
Baer, Jane
|
|
2010
|
28 |
4 |
p. 907-915
9 p.
|
article
|
| 5 |
Carbohydrate moieties as vaccine candidates: Meeting summary
|
Lucas, A.H.
|
|
2010
|
28 |
4 |
p. 1121-1131
11 p.
|
article
|
| 6 |
Comparative performance of a licensed anthrax vaccine versus electroporation based delivery of a PA encoding DNA vaccine in rhesus macaques
|
Livingston, Brian D.
|
|
2010
|
28 |
4 |
p. 1056-1061
6 p.
|
article
|
| 7 |
Comparison of the immunological responses and efficacy of gamma-irradiated V3526 vaccine formulations against subcutaneous and aerosol challenge with Venezuelan equine encephalitis virus subtype IAB
|
Martin, Shannon S.
|
|
2010
|
28 |
4 |
p. 1031-1040
10 p.
|
article
|
| 8 |
Cost-effectiveness analysis of Human Papillomavirus (HPV) Vaccination in the Netherlands: Recent publication reinforces favorable cost-effectiveness despite misleading conclusion
|
Postma, Maarten J.
|
|
2010
|
28 |
4 |
p. 873-874
2 p.
|
article
|
| 9 |
Declining invasive pneumococcal disease mortality in the United States, 1990–2005
|
Pulido, Marifi
|
|
2010
|
28 |
4 |
p. 889-892
4 p.
|
article
|
| 10 |
Design and delivery of a cryptic PrPC epitope for induction of PrPSc-specific antibody responses
|
Hedlin, Peter D.
|
|
2010
|
28 |
4 |
p. 981-988
8 p.
|
article
|
| 11 |
Design of antibody-reactive peptides from discontinuous parts of scorpion toxins
|
Alvarenga, L.
|
|
2010
|
28 |
4 |
p. 970-980
11 p.
|
article
|
| 12 |
Development and characterization of non-glycosylated E and NS1 mutant viruses as a potential candidate vaccine for West Nile virus
|
Whiteman, Melissa C.
|
|
2010
|
28 |
4 |
p. 1075-1083
9 p.
|
article
|
| 13 |
Difficulties in recruiting older people in clinical trials: An examination of barriers and solutions
|
Ridda, I.
|
|
2010
|
28 |
4 |
p. 901-906
6 p.
|
article
|
| 14 |
Double-blind, randomized, placebo-controlled Phase I Clinical Trial of the therapeutical antituberculous vaccine RUTI®
|
Vilaplana, C.
|
|
2010
|
28 |
4 |
p. 1106-1116
11 p.
|
article
|
| 15 |
Editorial Board
|
|
|
2010
|
28 |
4 |
p. CO2-
1 p.
|
article
|
| 16 |
Evaluation of live-attenuated Salmonella vaccines expressing Campylobacter antigens for control of C. jejuni in poultry
|
Buckley, Anthony M.
|
|
2010
|
28 |
4 |
p. 1094-1105
12 p.
|
article
|
| 17 |
Evaluation of the vaccine potential of a cytotoxic protease and a protective immunogen from a pathogenic Vibrio harveyi strain
|
Cheng, Shuang
|
|
2010
|
28 |
4 |
p. 1041-1047
7 p.
|
article
|
| 18 |
Field avian Metapneumovirus evolution avoiding vaccine induced immunity
|
Catelli, Elena
|
|
2010
|
28 |
4 |
p. 916-921
6 p.
|
article
|
| 19 |
Governments, off-patent vaccines, smallpox and universal childhood vaccination
|
Music, Stanley
|
|
2010
|
28 |
4 |
p. 869-872
4 p.
|
article
|
| 20 |
Hepatitis B vaccination strategies tailored to different endemicity levels: Some considerations
|
Rots, N.Y.
|
|
2010
|
28 |
4 |
p. 893-900
8 p.
|
article
|
| 21 |
Immunogenicity and tolerability of a virosome influenza vaccine compared to split influenza vaccine in patients with sickle cell anemia
|
Souza, Alessandra R.
|
|
2010
|
28 |
4 |
p. 1117-1120
4 p.
|
article
|
| 22 |
International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: Correlates of high Ad5 titers and implications for potential HIV vaccine trials
|
Mast, T. Christopher
|
|
2010
|
28 |
4 |
p. 950-957
8 p.
|
article
|
| 23 |
Monocytes transduced with lentiviral vectors expressing hepatitis C virus non-structural proteins and differentiated into dendritic cells stimulate multi-antigenic CD8+ T cell responses
|
Jirmo, Adan C.
|
|
2010
|
28 |
4 |
p. 922-933
12 p.
|
article
|
| 24 |
Mucosal delivery of antigens using adsorption to bacterial spores
|
Huang, Jen-Min
|
|
2010
|
28 |
4 |
p. 1021-1030
10 p.
|
article
|
| 25 |
Non-clinical efficacy and safety of HyVac4:IC31 vaccine administered in a BCG prime–boost regimen
|
Skeiky, Yasir A.W.
|
|
2010
|
28 |
4 |
p. 1084-1093
10 p.
|
article
|
| 26 |
[No title]
|
Garattini, L.
|
|
2010
|
28 |
4 |
p. 880-
1 p.
|
article
|
| 27 |
Parental attitude towards childhood HBV vaccination in The Netherlands
|
Hontelez, Jan A.C.
|
|
2010
|
28 |
4 |
p. 1015-1020
6 p.
|
article
|
| 28 |
Patient and clinic factors associated with adolescent human papillomavirus vaccine utilization within a university-based health system
|
Dempsey, Amanda
|
|
2010
|
28 |
4 |
p. 989-995
7 p.
|
article
|
| 29 |
Preventive HIV vaccine acceptability and behavioral risk compensation among high-risk men who have sex with men and transgenders in Thailand
|
Newman, Peter A.
|
|
2010
|
28 |
4 |
p. 958-964
7 p.
|
article
|
| 30 |
Quantitative anti-F1 and anti-V IgG ELISAs as serological correlates of protection against plague in female Swiss Webster mice
|
Little, S.F.
|
|
2010
|
28 |
4 |
p. 934-939
6 p.
|
article
|
| 31 |
Rates of autoimmune diseases in Kaiser Permanente for use in vaccine adverse event safety studies
|
Klein, Nicola P.
|
|
2010
|
28 |
4 |
p. 1062-1068
7 p.
|
article
|
| 32 |
Re: Detection of bluetongue virus genome after vaccination with an inactivated vaccine
|
Eschbaumer, Michael
|
|
2010
|
28 |
4 |
p. 881-882
2 p.
|
article
|
| 33 |
Salmonella enterica serovar Typhimurium mutants completely lacking the F0F1 ATPase are novel live attenuated vaccine strains
|
Northen, H.
|
|
2010
|
28 |
4 |
p. 940-949
10 p.
|
article
|
| 34 |
Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI)
|
Leav, Brett A.
|
|
2010
|
28 |
4 |
p. 965-969
5 p.
|
article
|
| 35 |
Serum levels of rubella-specific antibodies in Swedish women following three decades of vaccination programmes
|
Kakoulidou, Maria
|
|
2010
|
28 |
4 |
p. 1002-1007
6 p.
|
article
|
| 36 |
Smell impairment after tick-borne encephalitis vaccination: Case report
|
Vodička, J.
|
|
2010
|
28 |
4 |
p. 886-888
3 p.
|
article
|
| 37 |
The emm-type diversity does not always reflect the M protein genetic diversity—Is there a case for designer vaccine against GAS
|
Smeesters, Pierre R.
|
|
2010
|
28 |
4 |
p. 883-885
3 p.
|
article
|
| 38 |
Tick-borne encephalitis: From childhood to golden age does increased mobility mean increased risk?
|
Kunze, Ursula
|
|
2010
|
28 |
4 |
p. 875-876
2 p.
|
article
|
| 39 |
Vaccination of grouper broodfish (Epinephelus tukula) reduces the risk of vertical transmission by nervous necrosis virus
|
Kai, Yu-Hsuan
|
|
2010
|
28 |
4 |
p. 996-1001
6 p.
|
article
|
| 40 |
Vasculitis in a boy with ESRD following influenza vaccination
|
Catania, Piera
|
|
2010
|
28 |
4 |
p. 877-878
2 p.
|
article
|
| 41 |
ΔznuAΔpurE Brucella abortus 2308 mutant as a live vaccine candidate
|
Yang, Xinghong
|
|
2010
|
28 |
4 |
p. 1069-1074
6 p.
|
article
|
Journal description